Michigan will receive about $2.6 million as part of a multi-state settlement pertaining to the opioid Suboxone.
That’s according to a statement released Friday morning by Attorney General Dana Nessel’s office. The 32-state settlement resolves multiple allegations that manufacturer Reckitt Benckiser Group improperly sold and marketed the drug, which was designed to treat dependence on other opioid drugs.
Nessel’s office said the settlement money will be used primarily to reimburse the state’s Medicaid programs.
“The opioid crisis has ravaged Michigan communities across our state, and instead of helping combat it with life-saving medication, Reckitt appears to have exploited the crisis in an effort to bolster its bottom line,” Nessel said. “To any company that seeks to exploit a crisis for personal gain, know this: Putting profits over people will not stand in our state.”
The settlement with Reckitt is separate from a settlement that Nessel has negotiated with Purdue Pharma, another major opioid manufacturer.
Michigan’s share of the settlement comes from a July announcement by the U.S. Justice Department that it had obtained $1.4 billion from Reckitt.
“The opioid epidemic continues to be a serious crisis for our nation, and I’m proud of the work the Department of Justice and our partners are doing to address this epidemic,” Principal Deputy Associate Attorney General Claire Murray said in a statement at the time.
An average of 130 Americans die every day from opioid addiction, according to figures from the Centers for Disease Control and Prevention.